Pub Date : 2026-02-18DOI: 10.1016/j.placenta.2026.02.013
Malte Rolf, Sahan Jayatissa, Jonathan Reshef, Stefan Posch, Ellen Kuhl, Joanna L James, Alys R Clark, Hanna H Allerkamp
The placenta and uterus are essential to healthy human pregnancy, yet their complex adaptation and function remain difficult to study, particularly during the second trimester. Historical collections of placenta in situ specimens, including the Boyd, Dixon, and Carnegie Collections, provide rare access to placental and uterine anatomy across developmental stages and pathological conditions. Due to advancements in obstetric care, the preparation and extent of specimens in these collections is uncommon nowadays. They therefore offer a unique window into pregnancy that contemporary imaging cannot fully reproduce. This review article briefly summarizes these historical collections and examines how they can be integrated with modern imaging, machine learning, and multiscale modeling to extend their research utility. Advances in computational methods support the digitization and 3D reconstruction of 2D histological sections, helping to mitigate issues such as tissue deformation, staining variability, and missing sections. In addition, machine learning approaches enable automated segmentation, facilitating more detailed characterization of utero-placental structures and associated physiological functions. Image-based multiscale modeling can link microscale features, such as villous capillary architecture, to organ-scale responses including global perfusion and oxygen transport, while enabling efficient computation when enhanced with physics-informed neural networks or neural operators. These methods preserve the scientific value of legacy specimens while enabling new avenues for studying pregnancy complications such as preeclampsia and fetal growth restriction. By combining legacy resources with contemporary analytical techniques in an interdisciplinary framework, a more thorough understanding of placental biology and maternal-fetal health can be achieved that may inform future research and clinical applications.
{"title":"Reanimating the past: From historical collections of the placenta and uterus to modern imaging, machine learning, and multiscale modeling.","authors":"Malte Rolf, Sahan Jayatissa, Jonathan Reshef, Stefan Posch, Ellen Kuhl, Joanna L James, Alys R Clark, Hanna H Allerkamp","doi":"10.1016/j.placenta.2026.02.013","DOIUrl":"https://doi.org/10.1016/j.placenta.2026.02.013","url":null,"abstract":"<p><p>The placenta and uterus are essential to healthy human pregnancy, yet their complex adaptation and function remain difficult to study, particularly during the second trimester. Historical collections of placenta in situ specimens, including the Boyd, Dixon, and Carnegie Collections, provide rare access to placental and uterine anatomy across developmental stages and pathological conditions. Due to advancements in obstetric care, the preparation and extent of specimens in these collections is uncommon nowadays. They therefore offer a unique window into pregnancy that contemporary imaging cannot fully reproduce. This review article briefly summarizes these historical collections and examines how they can be integrated with modern imaging, machine learning, and multiscale modeling to extend their research utility. Advances in computational methods support the digitization and 3D reconstruction of 2D histological sections, helping to mitigate issues such as tissue deformation, staining variability, and missing sections. In addition, machine learning approaches enable automated segmentation, facilitating more detailed characterization of utero-placental structures and associated physiological functions. Image-based multiscale modeling can link microscale features, such as villous capillary architecture, to organ-scale responses including global perfusion and oxygen transport, while enabling efficient computation when enhanced with physics-informed neural networks or neural operators. These methods preserve the scientific value of legacy specimens while enabling new avenues for studying pregnancy complications such as preeclampsia and fetal growth restriction. By combining legacy resources with contemporary analytical techniques in an interdisciplinary framework, a more thorough understanding of placental biology and maternal-fetal health can be achieved that may inform future research and clinical applications.</p>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147309281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-13DOI: 10.1016/j.placenta.2026.02.009
Nicholas P Illsley, Stacy Zamudio
The differentiation of cytotrophoblast (CTB) into extravillous trophoblast (EVT) is central to development of the human placenta. This review explores the process by which CTB differentiate into invasive EVT. At its core is a mechanism known as the epithelial-mesenchymal transition (EMT), whereby immobile epithelial cells are transformed into an invasive, mesenchymal phenotype. Analysis of EMT-associated genes in first trimester CTB and EVT shows clear evidence of an EMT, promoting transition from CTB to EVT. The same analysis of third trimester cells shows evidence of an MET (mesenchymal-epithelial transition); EVT regress from the invasive first trimester mesenchymal phenotype to one characterized as mesenchymal but non-motile and non-proliferative. Of the EMT-master regulators, only the expression of the ZEB2 transcription factor showed a major increase in expression in first trimester EVT, which then reversed in third trimester cells. Overexpression of ZEB2 in trophoblast cell lines led to a pro-EMT shift in molecular markers, a more mesenchymal morphology and increased invasiveness, confirming its probable role in stimulating first trimester EMT. To confirm and compare the EMT observed in EVT with the several known types of EMT, we conducted a deeper gene expression analysis, enabling development of a trophoblast-specific EMT signature. Analysis of DNA methylation revealed genome-wide hypomethylation of third trimester EVT but also a small geneset with gains of methylation. EMT-associated genes showing a gain of methylation and differential expression comprised both pro-EMT and pro-MET genes, suggesting a regulated balance, maintaining the third trimester phenotype. The existence of multiple phenotypes on the EMT spectrum supports the concept of trophoblast epithelial-mesenchymal plasticity (EMP), with EMT-mediated generation of invasive first trimester cells followed by MET-assisted regression to the third trimester phenotype.
{"title":"Epithelial-mesenchymal plasticity in trophoblast differentiation.","authors":"Nicholas P Illsley, Stacy Zamudio","doi":"10.1016/j.placenta.2026.02.009","DOIUrl":"https://doi.org/10.1016/j.placenta.2026.02.009","url":null,"abstract":"<p><p>The differentiation of cytotrophoblast (CTB) into extravillous trophoblast (EVT) is central to development of the human placenta. This review explores the process by which CTB differentiate into invasive EVT. At its core is a mechanism known as the epithelial-mesenchymal transition (EMT), whereby immobile epithelial cells are transformed into an invasive, mesenchymal phenotype. Analysis of EMT-associated genes in first trimester CTB and EVT shows clear evidence of an EMT, promoting transition from CTB to EVT. The same analysis of third trimester cells shows evidence of an MET (mesenchymal-epithelial transition); EVT regress from the invasive first trimester mesenchymal phenotype to one characterized as mesenchymal but non-motile and non-proliferative. Of the EMT-master regulators, only the expression of the ZEB2 transcription factor showed a major increase in expression in first trimester EVT, which then reversed in third trimester cells. Overexpression of ZEB2 in trophoblast cell lines led to a pro-EMT shift in molecular markers, a more mesenchymal morphology and increased invasiveness, confirming its probable role in stimulating first trimester EMT. To confirm and compare the EMT observed in EVT with the several known types of EMT, we conducted a deeper gene expression analysis, enabling development of a trophoblast-specific EMT signature. Analysis of DNA methylation revealed genome-wide hypomethylation of third trimester EVT but also a small geneset with gains of methylation. EMT-associated genes showing a gain of methylation and differential expression comprised both pro-EMT and pro-MET genes, suggesting a regulated balance, maintaining the third trimester phenotype. The existence of multiple phenotypes on the EMT spectrum supports the concept of trophoblast epithelial-mesenchymal plasticity (EMP), with EMT-mediated generation of invasive first trimester cells followed by MET-assisted regression to the third trimester phenotype.</p>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147309323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-10DOI: 10.1016/j.placenta.2026.02.003
Stephen J Renaud
The placenta establishes a continuous epithelial barrier that separates maternal and fetal blood. The cell type lining this barrier is the syncytiotrophoblast (STB), an exceptional lineage comprising innumerable nuclei enclosed within a single uninterrupted cytoplasm. The STB mediates nutrient and gas exchange between maternal and fetal circulations and performs vital endocrine functions that modify maternal physiology to sustain pregnancy and support fetal growth. Maintenance of STB integrity is therefore critical for pregnancy success, and dysregulation of its formation and function is implicated in several severe pregnancy complications. As a postmitotic cell layer, STB expansion and renewal depend on underlying cytotrophoblasts exiting their progenitor state and fusing into the syncytium. Consequently, the STB contains nuclei and organelles of diverse ages, maturation states, and potentially distinct functions. Recent findings reveal substantial heterogeneity within STB nuclei, encompassing differences in transcriptional activity and chromatin organization. These variations may reflect nuclear age but could also represent an additional layer of transcriptional and epigenetic regulation required for syncytial function and stability. This review provides an overview of STB development and function, emphasizing epigenetic mechanisms that contribute to the structural and functional diversity of STB nuclei. Key gaps in knowledge are highlighted, including how nuclei interact and whether they can dynamically respond to changes in their local environment. Resolving these and other outstanding questions will advance our understanding of STB development, placental biology, and the pathophysiology of pregnancy complications.
{"title":"An epigenetic blueprint for placental syncytiotrophoblast development.","authors":"Stephen J Renaud","doi":"10.1016/j.placenta.2026.02.003","DOIUrl":"https://doi.org/10.1016/j.placenta.2026.02.003","url":null,"abstract":"<p><p>The placenta establishes a continuous epithelial barrier that separates maternal and fetal blood. The cell type lining this barrier is the syncytiotrophoblast (STB), an exceptional lineage comprising innumerable nuclei enclosed within a single uninterrupted cytoplasm. The STB mediates nutrient and gas exchange between maternal and fetal circulations and performs vital endocrine functions that modify maternal physiology to sustain pregnancy and support fetal growth. Maintenance of STB integrity is therefore critical for pregnancy success, and dysregulation of its formation and function is implicated in several severe pregnancy complications. As a postmitotic cell layer, STB expansion and renewal depend on underlying cytotrophoblasts exiting their progenitor state and fusing into the syncytium. Consequently, the STB contains nuclei and organelles of diverse ages, maturation states, and potentially distinct functions. Recent findings reveal substantial heterogeneity within STB nuclei, encompassing differences in transcriptional activity and chromatin organization. These variations may reflect nuclear age but could also represent an additional layer of transcriptional and epigenetic regulation required for syncytial function and stability. This review provides an overview of STB development and function, emphasizing epigenetic mechanisms that contribute to the structural and functional diversity of STB nuclei. Key gaps in knowledge are highlighted, including how nuclei interact and whether they can dynamically respond to changes in their local environment. Resolving these and other outstanding questions will advance our understanding of STB development, placental biology, and the pathophysiology of pregnancy complications.</p>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146197918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-09DOI: 10.1016/j.placenta.2026.02.006
Davis Laundon, Ella Proudley, Avery Pennington, Aaron Grewal, Philip J Basford, Orestis L Katsamenis, James Thompson, Patricia Goggin, Jeanette Norman, Dolapo Adebo, Samuel Kersley, Anandita Umapathy, Lottie Nesbitt, Georgina Constable-Dakeyne, Wendy Irvine, Neil J Gostling, Pascale Chavatte-Palmer, Bram G Sengers, Michele C Darrow, Rohan M Lewis
The mammalian placenta displays extraordinary structural diversity across scales of measurement, yet the quantitative basis and functional consequences of this variation remain poorly understood. Traditional approaches rely on qualitative categories or simple metrics such as length or depth which obscure the complexity of three-dimensional (3D) tissue architecture. Here, we review methods for quantifying whole-organ placental volume, surface area, and vascular organisation, highlighting trade-offs between speed, expense, labour, precision, scalability, destructivity, and specificity. We then demonstrate how correlative multiscale 3D imaging techniques can overcome these limitations, enabling whole-organ quantification across species spanning several orders of magnitude in placental volume-from mouse to rhinoceros. Using integrated workflows that combine X-ray microfocus tomography (microCT), light (H&E histology), and electron (SBF-SEM) microscopy, we generate quantitative structural datasets across spatial scales. In a mouse placenta, correlative 3D X-ray histology (3D-XRH) links histological features directly to their 3D tissue context. In a human placenta, multimodal imaging integrates whole-organ microCT with correlative X-ray and electron microscopy (CXEM) to quantify the total exchange surface area, bridging organ-scale structure and ultrastructural detail. Finally, using placentas from giraffes and rhinos, we show how microCT can be used to quantify the whole organ structure of placentas from even very large mammals, quantifying metrics such as cotyledon volume distribution and blood vessel architecture. Together, these examples illustrate the power of correlative multiscale 3D imaging to resolve mammalian placental structure, bridging cellular and organ-level organisation. This integrative approach provides a unified framework for quantitative comparative placentation, linking structural diversity to physiological function.
{"title":"From mice to rhinos: Whole-organ quantification of 3D mammalian placental structure using correlative multiscale imaging.","authors":"Davis Laundon, Ella Proudley, Avery Pennington, Aaron Grewal, Philip J Basford, Orestis L Katsamenis, James Thompson, Patricia Goggin, Jeanette Norman, Dolapo Adebo, Samuel Kersley, Anandita Umapathy, Lottie Nesbitt, Georgina Constable-Dakeyne, Wendy Irvine, Neil J Gostling, Pascale Chavatte-Palmer, Bram G Sengers, Michele C Darrow, Rohan M Lewis","doi":"10.1016/j.placenta.2026.02.006","DOIUrl":"https://doi.org/10.1016/j.placenta.2026.02.006","url":null,"abstract":"<p><p>The mammalian placenta displays extraordinary structural diversity across scales of measurement, yet the quantitative basis and functional consequences of this variation remain poorly understood. Traditional approaches rely on qualitative categories or simple metrics such as length or depth which obscure the complexity of three-dimensional (3D) tissue architecture. Here, we review methods for quantifying whole-organ placental volume, surface area, and vascular organisation, highlighting trade-offs between speed, expense, labour, precision, scalability, destructivity, and specificity. We then demonstrate how correlative multiscale 3D imaging techniques can overcome these limitations, enabling whole-organ quantification across species spanning several orders of magnitude in placental volume-from mouse to rhinoceros. Using integrated workflows that combine X-ray microfocus tomography (microCT), light (H&E histology), and electron (SBF-SEM) microscopy, we generate quantitative structural datasets across spatial scales. In a mouse placenta, correlative 3D X-ray histology (3D-XRH) links histological features directly to their 3D tissue context. In a human placenta, multimodal imaging integrates whole-organ microCT with correlative X-ray and electron microscopy (CXEM) to quantify the total exchange surface area, bridging organ-scale structure and ultrastructural detail. Finally, using placentas from giraffes and rhinos, we show how microCT can be used to quantify the whole organ structure of placentas from even very large mammals, quantifying metrics such as cotyledon volume distribution and blood vessel architecture. Together, these examples illustrate the power of correlative multiscale 3D imaging to resolve mammalian placental structure, bridging cellular and organ-level organisation. This integrative approach provides a unified framework for quantitative comparative placentation, linking structural diversity to physiological function.</p>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146197897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-12-03DOI: 10.1016/j.placenta.2025.12.002
Alina Edinger , Charlotte Cathrin Mohr , Elisa Marie Elfroth , Bernd Walkenfort , Sylvia Voortmann , Rainer Kimmig , Elke Winterhager , Alexandra Gellhaus
Introduction
The pregnancy disorder preeclampsia (PE) is characterized by maternal hypertension and reduced spiral artery (SpA) remodeling which is aggravated by increased levels of anti-angiogenic soluble fms-related tyrosine kinase 1 (sFLT1). One process contributing to physiological SpA remodeling in early pregnancy is the expression of lymphatic receptors on endothelial cells of SpAs, which is called lymphatic mimicry. Adverse lymphatic mimicry of SpAs is theorized to play a role in the pathophysiology of PE, but was not analyzed under preeclamptic conditions.
Methods
Using the transgenic PE/FGR mouse model with ubiquitous overexpression of human sFLT1 (hsFLT1), we focused on lymphatic marker expression in early pregnancy at 12.5 dpc and 14.5 dpc and evaluated the reduction of SpA remodeling as well as mRNA expression of lymphatic markers like Lyve1, Pdpn, or Prox1 in the mesometrial triangle (MT) of murine placentas. Additionally, uterine NK cell distribution was analyzed via electron microscopy and immunohistochemistry in placentas of PE animals.
Results
We could prove significantly reduced levels of Pdpn and Nrp1 mRNA in MT of PE placentas. Additionally, the mRNA expression of chemokines like Ccl21 were reduced at from 12.5 dpc until 14.5 dpc which could inhibit infiltration of uterine NK cell populations in these compartments in later pregnancy.
Discussion
With this study we could show that increased levels of human sFLT1 interfere with early spiral artery (SpA) remodeling processes and could inhibit lymphatic mimicry of SpA. Immune cell infiltration until 14.5 dpc could be decreased by downregulation of the chemotactic chemokine Ccl21.
{"title":"Lymphatic mimicry of spiral arteries is impaired by human sFLT1 overexpression in a preeclampsia mouse model","authors":"Alina Edinger , Charlotte Cathrin Mohr , Elisa Marie Elfroth , Bernd Walkenfort , Sylvia Voortmann , Rainer Kimmig , Elke Winterhager , Alexandra Gellhaus","doi":"10.1016/j.placenta.2025.12.002","DOIUrl":"10.1016/j.placenta.2025.12.002","url":null,"abstract":"<div><h3>Introduction</h3><div>The pregnancy disorder preeclampsia (PE) is characterized by maternal hypertension and reduced spiral artery (SpA) remodeling which is aggravated by increased levels of anti-angiogenic soluble fms-related tyrosine kinase 1 (sFLT1). One process contributing to physiological SpA remodeling in early pregnancy is the expression of lymphatic receptors on endothelial cells of SpAs, which is called lymphatic mimicry. Adverse lymphatic mimicry of SpAs is theorized to play a role in the pathophysiology of PE, but was not analyzed under preeclamptic conditions.</div></div><div><h3>Methods</h3><div>Using the transgenic PE/FGR mouse model with ubiquitous overexpression of human sFLT1 (hsFLT1), we focused on lymphatic marker expression in early pregnancy at 12.5 dpc and 14.5 dpc and evaluated the reduction of SpA remodeling as well as mRNA expression of lymphatic markers like <em>Lyve1</em>, <em>Pdpn</em>, or <em>Prox1</em> in the mesometrial triangle (MT) of murine placentas. Additionally, uterine NK cell distribution was analyzed via electron microscopy and immunohistochemistry in placentas of PE animals.</div></div><div><h3>Results</h3><div>We could prove significantly reduced levels of <em>Pdpn</em> and <em>Nrp1</em> mRNA in MT of PE placentas. Additionally, the mRNA expression of chemokines like <em>Ccl21</em> were reduced at from 12.5 dpc until 14.5 dpc which could inhibit infiltration of uterine NK cell populations in these compartments in later pregnancy.</div></div><div><h3>Discussion</h3><div>With this study we could show that increased levels of human sFLT1 interfere with early spiral artery (SpA) remodeling processes and could inhibit lymphatic mimicry of SpA. Immune cell infiltration until 14.5 dpc could be decreased by downregulation of the chemotactic chemokine <em>Ccl21</em>.</div></div>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":"174 ","pages":"Pages 53-62"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145687873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To investigate maternal serum levels of soluble suppression of tumorigenicity-2 (sST2) in pregnancies complicated by fetal growth restriction (FGR), and to evaluate its diagnostic utility and association with adverse neonatal outcomes.
Methods
This prospective observational study comprised 88 singleton pregnancies, including 44 FGR cases and 44 healthy controls matched for gestational age. FGR was classified as early or late onset using Delphi consensus criteria. Maternal serum sST2 levels were measured between 28 and 37 weeks of gestation by ELISA. Correlation analyzes and ROC curve analyzes were performed to evaluate diagnostic performance and associations with clinical parameters.
Results
sST2 levels were significantly higher in the FGR group compared to controls (p = 0.008). In the control group, sST2 levels showed a strong positive correlation with gestational age (r = 0.631, p < 0.001), no such correlation was observed in FGR pregnancies (r = 0.098, p = 0.529). ROC analysis demonstrated moderate diagnostic accuracy of sST2 for FGR (AUC = 0.665, p = 0.004), with high sensitivity (98 %) at a low cut-off (>0.28 ng/ml) and a specificity that reached 90 % at higher thresholds. sST2 also predicted adverse composite neonatal outcomes in FGR cases with an AUC of 0.689.
Discussion
Maternal serum sST2 levels are significantly elevated in FGR pregnancies and may serve as a biomarker for placental dysfunction. Although the sST2 level is not specific enough as a stand-alone diagnostic tool, it can help in risk stratification when used in conjunction with other clinical or biochemical markers.
研究妊娠合并胎儿生长受限(FGR)孕妇血清可溶性抑制致瘤性-2 (sST2)水平,并评估其诊断价值及其与新生儿不良结局的关系。方法本前瞻性观察研究纳入88例单胎妊娠,包括44例FGR病例和44例胎龄匹配的健康对照。使用德尔菲共识标准将FGR分为早发或晚发。采用ELISA法测定妊娠28 ~ 37周孕妇血清sST2水平。进行相关分析和ROC曲线分析,评价诊断效能及其与临床参数的相关性。结果FGR组ssst2水平显著高于对照组(p = 0.008)。在对照组中,sST2水平与胎龄呈正相关(r = 0.631, p < 0.001),在FGR妊娠组中,sST2水平与胎龄无相关性(r = 0.098, p = 0.529)。ROC分析显示,sST2对FGR的诊断准确度中等(AUC = 0.665, p = 0.004),在低临界值(>0.28 ng/ml)下具有高灵敏度(98%),在较高阈值下特异性达到90%。sST2还预测FGR病例的不良综合新生儿结局,AUC为0.689。FGR孕妇血清sST2水平显著升高,可作为胎盘功能障碍的生物标志物。虽然sST2水平作为一种单独的诊断工具不够特异性,但当与其他临床或生化指标结合使用时,它可以帮助进行风险分层。
{"title":"Maternal soluble suppression of Tumorigenicity-2 as a biomarker for fetal growth restriction: Clinical correlations and diagnostic performance","authors":"Sadun Sucu , Sadullah Özkan , Alperen Aksan , Dilara Kurt , Belgin Savran Üçok , Turhan Çağlar","doi":"10.1016/j.placenta.2026.01.004","DOIUrl":"10.1016/j.placenta.2026.01.004","url":null,"abstract":"<div><h3>Introduction</h3><div>To investigate maternal serum levels of soluble suppression of tumorigenicity-2 (sST2) in pregnancies complicated by fetal growth restriction (FGR), and to evaluate its diagnostic utility and association with adverse neonatal outcomes.</div></div><div><h3>Methods</h3><div>This prospective observational study comprised 88 singleton pregnancies, including 44 FGR cases and 44 healthy controls matched for gestational age. FGR was classified as early or late onset using Delphi consensus criteria. Maternal serum sST2 levels were measured between 28 and 37 weeks of gestation by ELISA. Correlation analyzes and ROC curve analyzes were performed to evaluate diagnostic performance and associations with clinical parameters.</div></div><div><h3>Results</h3><div>sST2 levels were significantly higher in the FGR group compared to controls (p = 0.008). In the control group, sST2 levels showed a strong positive correlation with gestational age (r = 0.631, p < 0.001), no such correlation was observed in FGR pregnancies (r = 0.098, p = 0.529). ROC analysis demonstrated moderate diagnostic accuracy of sST2 for FGR (AUC = 0.665, p = 0.004), with high sensitivity (98 %) at a low cut-off (>0.28 ng/ml) and a specificity that reached 90 % at higher thresholds. sST2 also predicted adverse composite neonatal outcomes in FGR cases with an AUC of 0.689.</div></div><div><h3>Discussion</h3><div>Maternal serum sST2 levels are significantly elevated in FGR pregnancies and may serve as a biomarker for placental dysfunction. Although the sST2 level is not specific enough as a stand-alone diagnostic tool, it can help in risk stratification when used in conjunction with other clinical or biochemical markers.</div></div>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":"174 ","pages":"Pages 245-253"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145976780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-01-06DOI: 10.1016/j.placenta.2026.01.002
Lylach Haizler-Cohen , Guisong Wang , Tesfa Dejenie Habtewold , Prabhavi Wijesiriwardhana , Katherine L. Grantz , Fasil Tekola-Ayele
Introduction
Nulliparity is associated with adverse pregnancy outcomes including preeclampsia, preterm birth, lower birth weight and stillbirth although mechanisms are unclear. Placental gene expression differences, which also vary by fetal sex, may drive altered placental function and explain pregnancy outcome differences between nulliparous and multiparous women. This study aims to identify placental gene expression differences based on parity and examine their relationship with birth weight.
Methods
RNA sequencing was performed on placental samples collected at delivery as part of the NICHD Fetal Growth Studies. Differentially expressed genes between placentas of nulliparous (n = 34) and multiparous (n = 41) participants were determined in the full cohort and stratified by fetal sex. Weighted gene co-expression network analysis was performed to identify co-expression modules associated with parity. Correlation of differentially expressed genes and co-expression modules with birth weight was assessed.
Results
Five differentially expressed genes were identified (FDR p < 0.05) including DDX5 (higher expression in multiparas in full cohort), ANKRD33 and SLITRK6 (higher in multiparas in female sub-cohort), and IL1B and MTCO1P40 (higher in nulliparas in female sub-cohort). Two gene co-expression modules, “Grey60” and “Tan”, were negatively associated with multiparity. The DDX5 and ILB1 genes, and the “Grey60” module were significantly correlated with birth weight within the parity group that exhibited lower expression. Genes in the two co-expression modules were enriched for pathways related to immune response, cardiovascular and reproductive system development, and cancer.
Discussion
Placental gene expression differences between nulliparas and multiparas may in part underlie neonatal outcomes that differ by parity and fetal sex.
无产与不良妊娠结局相关,包括先兆子痫、早产、低出生体重和死胎,但机制尚不清楚。胎盘基因表达的差异,也因胎儿性别而异,可能导致胎盘功能的改变,并解释了无产和多产妇女妊娠结局的差异。本研究旨在确定基于胎次的胎盘基因表达差异,并研究其与出生体重的关系。方法对分娩时收集的胎盘样本进行srna测序,作为NICHD胎儿生长研究的一部分。在全队列中,对未产(n = 34)和多产(n = 41)受试者的胎盘差异表达基因进行了测定,并按胎儿性别分层。进行加权基因共表达网络分析,以确定与胎次相关的共表达模块。评估差异表达基因和共表达模块与出生体重的相关性。结果共鉴定出5个差异表达基因(FDR p < 0.05),包括DDX5(在完整队列中多paras中表达较高)、ANKRD33和SLITRK6(在女性亚队列中多paras中表达较高)、IL1B和MTCO1P40(在女性亚队列中无paras中表达较高)。两个基因共表达模块“Grey60”和“Tan”与多胎呈负相关。在低表达胎次组中,DDX5和ILB1基因以及“Grey60”模块与出生体重显著相关。两个共表达模块中的基因丰富,与免疫反应、心血管和生殖系统发育以及癌症相关。无胎和多胎胎盘基因表达的差异可能在一定程度上导致胎次和胎儿性别不同的新生儿结局。
{"title":"Placental gene expression signatures based on maternal parity","authors":"Lylach Haizler-Cohen , Guisong Wang , Tesfa Dejenie Habtewold , Prabhavi Wijesiriwardhana , Katherine L. Grantz , Fasil Tekola-Ayele","doi":"10.1016/j.placenta.2026.01.002","DOIUrl":"10.1016/j.placenta.2026.01.002","url":null,"abstract":"<div><h3>Introduction</h3><div>Nulliparity is associated with adverse pregnancy outcomes including preeclampsia, preterm birth, lower birth weight and stillbirth although mechanisms are unclear. Placental gene expression differences, which also vary by fetal sex, may drive altered placental function and explain pregnancy outcome differences between nulliparous and multiparous women. This study aims to identify placental gene expression differences based on parity and examine their relationship with birth weight.</div></div><div><h3>Methods</h3><div>RNA sequencing was performed on placental samples collected at delivery as part of the NICHD Fetal Growth Studies. Differentially expressed genes between placentas of nulliparous (n = 34) and multiparous (n = 41) participants were determined in the full cohort and stratified by fetal sex. Weighted gene co-expression network analysis was performed to identify co-expression modules associated with parity. Correlation of differentially expressed genes and co-expression modules with birth weight was assessed.</div></div><div><h3>Results</h3><div>Five differentially expressed genes were identified (FDR p < 0.05) including <em>DDX5</em> (higher expression in multiparas in full cohort), <em>ANKRD33</em> and <em>SLITRK6</em> (higher in multiparas in female sub-cohort), and <em>IL1B</em> and <em>MTCO1P40</em> (higher in nulliparas in female sub-cohort). Two gene co-expression modules, “Grey60” and “Tan”, were negatively associated with multiparity. The <em>DDX5</em> and <em>ILB1</em> genes, and the “Grey60” module were significantly correlated with birth weight within the parity group that exhibited lower expression. Genes in the two co-expression modules were enriched for pathways related to immune response, cardiovascular and reproductive system development, and cancer.</div></div><div><h3>Discussion</h3><div>Placental gene expression differences between nulliparas and multiparas may in part underlie neonatal outcomes that differ by parity and fetal sex.</div></div>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":"174 ","pages":"Pages 214-224"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145925047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-10-09DOI: 10.1016/j.placenta.2025.10.008
Nora Schaumann , Nadine Mand , Tanja Groten , Grit Gesine Ruth Hiller , Kristin Andresen , Johanna Büchel , Jana Pastuschek , Ulrich Pecks
Background
During the COVID-19 pandemic, reports of stillbirths associated with SARS-CoV-2 infection increased. This study aims to assess whether and to what extent these stillbirths are associated with placental changes and specific viral variants.
Methods
Data from the multicenter, prospective CRONOS registry (COVID-19-Related Obstetric and Neonatal Outcome Study) including 8032 women infected with SARS-CoV-2 during their pregnancy were analyzed. In case of stillbirth, additional data were obtained by contacting the respective clinic.
Results
Data on pregnancy outcomes were available for 7224 women giving birth after 22 + 0 weeks of gestational age. Cases with chromosomal disorders or severe congenital malformations were excluded from the analysis. 45 women had a stillbirth, the stillbirth rate was 0.6 %. 13 children were born in the wild-type phase, 11 with Alpha and Delta each, and 10 with Omicron. For the corresponding number of women in each phase, the stillbirth rates were 0.6 %, 1.6 %, 0.8 % and 0.3 %, respectively (p = 0.002). Placental pathology, available from 23 of the 45 stillbirths, showed features of SARS-CoV-2 placentitis in 10 of 14 placentas (71 %) in the Alpha and Delta phases. In contrast, no features of SARS-CoV-2 placentitis were described in the wild-type and Omicron phases.
Conclusions
The CRONOS data confirm a virus-type-dependent effect of the Alpha and Delta variants on the placenta with a possible causal effect on stillbirth. In the context of an infection, targeted fetal monitoring appears appropriate. A stillbirth due to COVID-19 is unlikely more than 4 weeks after infection.
{"title":"Influence of SARS-CoV-2 variants on stillbirth rate - data from the CRONOS registry","authors":"Nora Schaumann , Nadine Mand , Tanja Groten , Grit Gesine Ruth Hiller , Kristin Andresen , Johanna Büchel , Jana Pastuschek , Ulrich Pecks","doi":"10.1016/j.placenta.2025.10.008","DOIUrl":"10.1016/j.placenta.2025.10.008","url":null,"abstract":"<div><h3>Background</h3><div>During the COVID-19 pandemic, reports of stillbirths associated with SARS-CoV-2 infection increased. This study aims to assess whether and to what extent these stillbirths are associated with placental changes and specific viral variants.</div></div><div><h3>Methods</h3><div>Data from the multicenter, prospective CRONOS registry (COVID-19-Related Obstetric and Neonatal Outcome Study) including 8032 women infected with SARS-CoV-2 during their pregnancy were analyzed. In case of stillbirth, additional data were obtained by contacting the respective clinic.</div></div><div><h3>Results</h3><div>Data on pregnancy outcomes were available for 7224 women giving birth after 22 + 0 weeks of gestational age. Cases with chromosomal disorders or severe congenital malformations were excluded from the analysis. 45 women had a stillbirth, the stillbirth rate was 0.6 %. 13 children were born in the wild-type phase, 11 with Alpha and Delta each, and 10 with Omicron. For the corresponding number of women in each phase, the stillbirth rates were 0.6 %, 1.6 %, 0.8 % and 0.3 %, respectively (p = 0.002). Placental pathology, available from 23 of the 45 stillbirths, showed features of SARS-CoV-2 placentitis in 10 of 14 placentas (71 %) in the Alpha and Delta phases. In contrast, no features of SARS-CoV-2 placentitis were described in the wild-type and Omicron phases.</div></div><div><h3>Conclusions</h3><div>The CRONOS data confirm a virus-type-dependent effect of the Alpha and Delta variants on the placenta with a possible causal effect on stillbirth. In the context of an infection, targeted fetal monitoring appears appropriate. A stillbirth due to COVID-19 is unlikely more than 4 weeks after infection.</div></div>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":"174 ","pages":"Pages 43-52"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-12-14DOI: 10.1016/j.placenta.2025.12.007
Ana María Arboleda-Borrero , Eliécer Jiménez-Charris , Laura Andrea Gómez , Wilmar Saldarriaga , Javier Fonseca , Mildrey Mosquera Escudero
Background
The NLRP3 inflammasome is a key regulator of innate immunity. Its overactivation contributes to cytokine release and tissue inflammation during SARS-CoV-2 infection. However, its role in placental inflammation and pregnancy outcomes remains unclear.
Objective
To evaluate whether SARS-CoV-2 infection during pregnancy induces NLRP3 inflammasome activation in placental tissue and to assess its association with maternal and neonatal outcomes.
Methods
A prospective cohort study included 25 pregnant women with RT-PCR–confirmed COVID-19 and 25 healthy controls. Placental NLRP3, Caspase-1, IL-1β, and IL-18 expression were analyzed by qRT-PCR and Western blotting. Maternal and cord plasma cytokines were quantified by ELISA and cytometric bead array. Viral RNA, antibody transfer, and nutrient transporter gene expression were also evaluated.
Results
Placentas from infected women showed higher NLRP3 (p = 0.015) and Caspase-1 (p = 0.029) mRNA levels compared with controls. Western blotting detected procaspase-1 (∼50 kDa) and cleaved caspase-1 (∼35 kDa), indicating inflammasome activation. Maternal IL-18 concentrations were elevated (p = 0.013), while IL-1β remained unchanged. SARS-CoV-2 RNA was identified in 8 % of placentas (variants 21H and 20A). IgG antibodies were found in 28 % of maternal and 24 % of cord samples (p = 0.017). Infected pregnancies showed lower gestational age at delivery (p = 0.023), higher cesarean rate (p = 0.004), and lower neonatal Apgar scores (p = 0.006, p = 0.015). Nutrient transporter expression was preserved.
Conclusion
SARS-CoV-2 infection during pregnancy induces activation of the NLRP3 inflammasome in placental tissue and systemic elevation of IL-18, indicating both local and systemic inflammation.
{"title":"NLRP3 inflammasome activation in the placenta during SARS-CoV-2 infection","authors":"Ana María Arboleda-Borrero , Eliécer Jiménez-Charris , Laura Andrea Gómez , Wilmar Saldarriaga , Javier Fonseca , Mildrey Mosquera Escudero","doi":"10.1016/j.placenta.2025.12.007","DOIUrl":"10.1016/j.placenta.2025.12.007","url":null,"abstract":"<div><h3>Background</h3><div>The NLRP3 inflammasome is a key regulator of innate immunity. Its overactivation contributes to cytokine release and tissue inflammation during SARS-CoV-2 infection. However, its role in placental inflammation and pregnancy outcomes remains unclear.</div></div><div><h3>Objective</h3><div>To evaluate whether SARS-CoV-2 infection during pregnancy induces NLRP3 inflammasome activation in placental tissue and to assess its association with maternal and neonatal outcomes.</div></div><div><h3>Methods</h3><div>A prospective cohort study included 25 pregnant women with RT-PCR–confirmed COVID-19 and 25 healthy controls. Placental <em>NLRP3</em>, <em>Caspase-1</em>, <em>IL-1β</em>, and <em>IL-18</em> expression were analyzed by qRT-PCR and Western blotting. Maternal and cord plasma cytokines were quantified by ELISA and cytometric bead array. Viral RNA, antibody transfer, and nutrient transporter gene expression were also evaluated.</div></div><div><h3>Results</h3><div>Placentas from infected women showed higher <em>NLRP3</em> (p = 0.015) and <em>Caspase-1</em> (p = 0.029) mRNA levels compared with controls. Western blotting detected procaspase-1 (∼50 kDa) and cleaved caspase-1 (∼35 kDa), indicating inflammasome activation. Maternal IL-18 concentrations were elevated (p = 0.013), while IL-1β remained unchanged. SARS-CoV-2 RNA was identified in 8 % of placentas (variants 21H and 20A). IgG antibodies were found in 28 % of maternal and 24 % of cord samples (p = 0.017). Infected pregnancies showed lower gestational age at delivery (p = 0.023), higher cesarean rate (p = 0.004), and lower neonatal Apgar scores (p = 0.006, p = 0.015). Nutrient transporter expression was preserved.</div></div><div><h3>Conclusion</h3><div>SARS-CoV-2 infection during pregnancy induces activation of the NLRP3 inflammasome in placental tissue and systemic elevation of IL-18, indicating both local and systemic inflammation.</div></div>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":"174 ","pages":"Pages 117-125"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145794621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-21DOI: 10.1016/j.placenta.2025.11.008
C.M. van Kammen , F.M. Al Darwish , G.J. Strijkers , B.F. Coolen , L.K. Alles , M.M. Faas , R. Schiffelers , A.T. Lely , F. Terstappen
Background
Placental insufficiency underlies major obstetric complications such as preeclampsia and fetal growth restriction (FGR). The reduced uterine perfusion pressure (RUPP) model is widely used to mimic PE and FGR; however, its impact on placental structure, immune cell regulation, and vascular remodeling in the mesometrial triangle remains poorly examined. This study investigates these processes to clarify the model's relevance for human placenta dysfunction pathology.
Methods
Maternal, fetal, and placental parameters were assessed in pregnant rats at gestational day (GD) 14, 16, 18, and 19, comparing normal pregnant and RUPP groups. Placental morphology was assessed using hematoxylin and eosin staining. Within the mesometrial triangle, uterine natural killer (uNK) cell distribution was evaluated using ANK61 staining, while trophoblast invasion and spiral artery remodeling were assessed by pan-cytokeratin and α-SMA staining, respectively.
Results
Placental macrostructural architecture was preserved in RUPP. However, uNK cell migration from the mesometrial triangle was impaired, with higher ANK61-positive cell presence persisting at GD19. This was accompanied by a reduction in trophoblast invasion depth. Spiral artery remodeling was impaired in RUPP placentas, with a greater proportion of unremodeled vessels and fewer highly remodeled arteries by GD19.
Conclusion
While gross placental structure remains intact in the RUPP model, the key functional adaptations uNK cell migration, trophoblast invasion, and vascular remodeling, are impaired. These findings support the RUPP as a relevant model to study the pathophysiological mechanisms of placental insufficiency. Future research should focus on temporal molecular profiling to elucidate the mechanisms behind impaired uNK cell retention and shallow trophoblast invasion.
{"title":"Impaired placental vascular remodeling and persistent uNK cells in the RUPP model: A time-dependent perspective","authors":"C.M. van Kammen , F.M. Al Darwish , G.J. Strijkers , B.F. Coolen , L.K. Alles , M.M. Faas , R. Schiffelers , A.T. Lely , F. Terstappen","doi":"10.1016/j.placenta.2025.11.008","DOIUrl":"10.1016/j.placenta.2025.11.008","url":null,"abstract":"<div><h3>Background</h3><div>Placental insufficiency underlies major obstetric complications such as preeclampsia and fetal growth restriction (FGR). The reduced uterine perfusion pressure (RUPP) model is widely used to mimic PE and FGR; however, its impact on placental structure, immune cell regulation, and vascular remodeling in the mesometrial triangle remains poorly examined. This study investigates these processes to clarify the model's relevance for human placenta dysfunction pathology.</div></div><div><h3>Methods</h3><div>Maternal, fetal, and placental parameters were assessed in pregnant rats at gestational day (GD) 14, 16, 18, and 19, comparing normal pregnant and RUPP groups. Placental morphology was assessed using hematoxylin and eosin staining. Within the mesometrial triangle, uterine natural killer (uNK) cell distribution was evaluated using ANK61 staining, while trophoblast invasion and spiral artery remodeling were assessed by pan-cytokeratin and α-SMA staining, respectively.</div></div><div><h3>Results</h3><div>Placental macrostructural architecture was preserved in RUPP. However, uNK cell migration from the mesometrial triangle was impaired, with higher ANK61-positive cell presence persisting at GD19. This was accompanied by a reduction in trophoblast invasion depth. Spiral artery remodeling was impaired in RUPP placentas, with a greater proportion of unremodeled vessels and fewer highly remodeled arteries by GD19.</div></div><div><h3>Conclusion</h3><div>While gross placental structure remains intact in the RUPP model, the key functional adaptations uNK cell migration, trophoblast invasion, and vascular remodeling, are impaired. These findings support the RUPP as a relevant model to study the pathophysiological mechanisms of placental insufficiency. Future research should focus on temporal molecular profiling to elucidate the mechanisms behind impaired uNK cell retention and shallow trophoblast invasion.</div></div>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":"174 ","pages":"Pages 1-8"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145584492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}